Jeffrey W Sherman Strongbridge Biopharma PLC (SBBP) insider trading activity

Jeffrey W Sherman is Director of Strongbridge Biopharma plc. Currently has a direct ownership of 0 shares of SBBP, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 64,258 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

JEFFREY W SHERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2021	SELL Sale (or disposition) back to the issuer	-	64,258 Reduced 100.0%	0 Ordinary Shares
Oct 01 2021	SELL Payment of exercise price or tax liability	$36,592 $2.06 p/Share	17,763 Reduced 21.66%	64,258 Ordinary Shares
May 18 2021	BUY Grant, award, or other acquisition	-	40,000 Added 32.78%	82,021 Ordinary Shares
May 14 2021	SELL Payment of exercise price or tax liability	$44,518 $2.35 p/Share	18,944 Reduced 31.07%	42,021 Ordinary Shares

Also insider at

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

EVP and Chief Medical Officer

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

XERS

Xeris Biopharma Holdings, Inc. Healthcare

Director

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

JWS